Pharmacokinetics and Safety of MNK-155 in Postsurgical Adolescent Subjects With Moderate to Severe Acute Pain
Status:
Withdrawn
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
An open-label study of the pharmacokinetics (PK) and safety of MNK-155 in postsurgical
adolescent subjects aged 12 to 17 years with moderate to severe acute pain. The study will
assess the safety of administering multiple doses of MNK-155 in this population.